Biologically active orcinol-based secondary metabolites originated from lichens

Authors

  • Boddu Rama Krishna Department of Energy Engineering and School of Energy and Chemical Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea
  • Narayana Rao Gundoju Department of Chemistry, M. R. Degree College, Fort, Andhra Pradesh 535002, India
  • Tiruveedhula Somasekhar Department of Chemistry, S.V.R.M College Nagaram, Guntur, Andhra Pradesh 522268, India
  • Waill Elkhateeb Chemistry of Natural and Microbial Products Department, Pharmaceutical Industries Division, National Research Centre, Dokki, Giza 12622, Egypt
  • Ghoson Daba Chemistry of Natural and Microbial Products Department, Pharmaceutical Industries Division, National Research Centre, Dokki, Giza 12622, Egypt

DOI:

https://doi.org/10.36547/nbc.1075

Keywords:

Lichens, Natural products, Secondary metabolites

Abstract

Lichens have attracted considerable interest since ancient time due to their medicinal properties. Lichen produce a variety of orcinol-based compounds such as xanthones, anthraquinones, dibenzofurans, depsides, and depsidones. Several related compounds have shown potent bioactivities as antiviral, antioxidant, anti-herbivore, insecticidal, antifungal, and anticancer. Lichens have been employed as traditional medicines, and these are continuing to be of great interest for their biotechnological potential. The purpose of this review was to systematically evaluate the literature on the orcinol based biologically active secondary metabolites of lichen.

Downloads

Published

2022-06-03

How to Cite

Krishna, B. R., Gundoju, N. R., Somasekhar, T. ., Elkhateeb, W., & Daba, G. (2022). Biologically active orcinol-based secondary metabolites originated from lichens . Nova Biotechnologica Et Chimica, 21(1), e1075. https://doi.org/10.36547/nbc.1075

Issue

Vol. 21 No. 1 (2022)

Section

Reviews

License

Copyright (c) 2022 Boddu Rama Krishna, Narayana Rao Gundoju, Tiruveedhula Somasekhar, Waill Elkhateeb, Ghoson Daba

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers published in the Nova Biotechnologica et Chimica (NBC)  are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).